{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T17:52:03Z","timestamp":1790704323477,"version":"4.1.0"},"reference-count":106,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:00:00Z","timestamp":1563321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["4R01HL116391-04"],"award-info":[{"award-number":["4R01HL116391-04"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>de novo<\/jats:italic> fatty acid biosynthesis (DNFA) is a hallmark adaptation of many cancers that supports survival, proliferation, and metastasis. Here we elucidate previously unexplored aspects of transcription regulation and clinical relevance of DNFA in cancers. We show that elevated expression of DNFA genes is characteristic of many tumor types and correlates with poor prognosis, especially in melanomas. Elevated DNFA gene expression depends on the SREBP1 transcription factor in multiple melanoma cell lines. SREBP1 predominantly binds to the transcription start sites of DNFA genes, regulating their expression by recruiting\u00a0RNA polymerase II to promoters for productive transcription elongation. We find that SREBP1-regulated DNFA represents a survival trait in melanoma cells, regardless of proliferative state and oncogenic mutation status. Indeed, malignant melanoma cells exhibit elevated DNFA gene expression after the BRAF\/MEK signaling pathway is blocked (e.g. by BRAF inhibitors), and DNFA expression remains higher in melanoma cells resistant to vemurafenib treatment than in untreated cells. Accordingly, DNFA pathway inhibition, whether by direct targeting of SREBP1 with antisense oligonucleotides, or through combinatorial effects of multiple DNFA enzyme inhibitors, exerts potent cytotoxic effects on both BRAFi-sensitive and -resistant melanoma cells. Altogether, these results implicate SREBP1 and DNFA enzymes as enticing therapeutic targets in melanomas.<\/jats:p>","DOI":"10.1038\/s41598-019-46594-x","type":"journal-article","created":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T10:02:43Z","timestamp":1563357763000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["SREBP1-dependent de novo fatty acid synthesis gene expression is elevated in malignant melanoma and represents a cellular survival trait"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7317-3389","authenticated-orcid":false,"given":"Su","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders M.","family":"N\u00e4\u00e4r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,17]]},"reference":[{"key":"46594_CR1","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1038\/nrc2981","volume":"11","author":"RA Cairns","year":"2011","unstructured":"Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nature reviews. Cancer 11, 85\u201395, https:\/\/doi.org\/10.1038\/nrc2981 (2011).","journal-title":"Nature reviews. Cancer"},{"key":"46594_CR2","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1126\/science.1160809","volume":"324","author":"MG Vander Heiden","year":"2009","unstructured":"Vander Heiden, M. G., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029\u20131033, https:\/\/doi.org\/10.1126\/science.1160809 (2009).","journal-title":"Science"},{"key":"46594_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden, M. G. & DeBerardinis, R. J. Understanding the Intersections between Metabolism and Cancer Biology. Cell 168, 657\u2013669, https:\/\/doi.org\/10.1016\/j.cell.2016.12.039 (2017).","journal-title":"Cell"},{"key":"46594_CR4","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.cmet.2013.05.017","volume":"18","author":"E Currie","year":"2013","unstructured":"Currie, E., Schulze, A., Zechner, R., Walther, T. C. & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab 18, 153\u2013161, https:\/\/doi.org\/10.1016\/j.cmet.2013.05.017 (2013).","journal-title":"Cell Metab"},{"key":"46594_CR5","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1038\/nrc2222","volume":"7","author":"JA Menendez","year":"2007","unstructured":"Menendez, J. A. & Lupu, R. Fatty acid synthase and the lipogenic phenotype in cancer pathogenesis. Nature reviews. Cancer 7, 763\u2013777, https:\/\/doi.org\/10.1038\/nrc2222 (2007).","journal-title":"Nature reviews. Cancer"},{"key":"46594_CR6","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1038\/nrm4074","volume":"16","author":"Y Wang","year":"2015","unstructured":"Wang, Y., Viscarra, J., Kim, S. J. & Sul, H. S. Transcriptional regulation of hepatic lipogenesis. Nature reviews. Molecular cell biology 16, 678\u2013689, https:\/\/doi.org\/10.1038\/nrm4074 (2015).","journal-title":"Nature reviews. Molecular cell biology"},{"issue":"Suppl","key":"46594_CR7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1194\/jlr.R800054-JLR200","volume":"50","author":"MS Brown","year":"2009","unstructured":"Brown, M. S. & Goldstein, J. L. Cholesterol feedback: from Schoenheimer\u2019s bottle to Scap\u2019s MELADL. Journal of lipid research 50(Suppl), S15\u201327, https:\/\/doi.org\/10.1194\/jlr.R800054-JLR200 (2009).","journal-title":"Journal of lipid research"},{"key":"46594_CR8","doi-asserted-by":"publisher","first-page":"35840","DOI":"10.1074\/jbc.274.50.35840","volume":"274","author":"N Yahagi","year":"1999","unstructured":"Yahagi, N. et al. A crucial role of sterol regulatory element-binding protein-1 in the regulation of lipogenic gene expression by polyunsaturated fatty acids. The Journal of biological chemistry 274, 35840\u201335844 (1999).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR9","doi-asserted-by":"publisher","first-page":"23577","DOI":"10.1074\/jbc.274.33.23577","volume":"274","author":"J Xu","year":"1999","unstructured":"Xu, J., Nakamura, M. T., Cho, H. P. & Clarke, S. D. Sterol regulatory element binding protein-1 expression is suppressed by dietary polyunsaturated fatty acids. A mechanism for the coordinate suppression of lipogenic genes by polyunsaturated fats. The Journal of biological chemistry 274, 23577\u201323583 (1999).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR10","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1128\/MCB.19.5.3760","volume":"19","author":"M Foretz","year":"1999","unstructured":"Foretz, M. et al. ADD1\/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Molecular and cellular biology 19, 3760\u20133768 (1999).","journal-title":"Molecular and cellular biology"},{"key":"46594_CR11","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1101\/gad.10.9.1096","volume":"10","author":"JB Kim","year":"1996","unstructured":"Kim, J. B. & Spiegelman, B. M. ADD1\/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev 10, 1096\u20131107 (1996).","journal-title":"Genes Dev"},{"key":"46594_CR12","doi-asserted-by":"publisher","first-page":"6358","DOI":"10.1073\/pnas.0931394100","volume":"100","author":"SS Chirala","year":"2003","unstructured":"Chirala, S. S. et al. Fatty acid synthesis is essential in embryonic development: fatty acid synthase null mutants and most of the heterozygotes die in utero. Proceedings of the National Academy of Sciences of the United States of America 100, 6358\u20136363, https:\/\/doi.org\/10.1073\/pnas.0931394100 (2003).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"46594_CR13","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1172\/JCI15593","volume":"109","author":"JD Horton","year":"2002","unstructured":"Horton, J. D., Goldstein, J. L. & Brown, M. S. SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. The Journal of clinical investigation 109, 1125\u20131131, https:\/\/doi.org\/10.1172\/JCI15593 (2002).","journal-title":"The Journal of clinical investigation"},{"key":"46594_CR14","doi-asserted-by":"publisher","first-page":"32379","DOI":"10.1074\/jbc.R000017200","volume":"275","author":"TF Osborne","year":"2000","unstructured":"Osborne, T. F. Sterol regulatory element-binding proteins (SREBPs): key regulators of nutritional homeostasis and insulin action. The Journal of biological chemistry 275, 32379\u201332382, https:\/\/doi.org\/10.1074\/jbc.R000017200 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR15","doi-asserted-by":"publisher","first-page":"11681","DOI":"10.1074\/jbc.M109.096107","volume":"285","author":"Y Takeuchi","year":"2010","unstructured":"Takeuchi, Y. et al. Polyunsaturated fatty acids selectively suppress sterol regulatory element-binding protein-1 through proteolytic processing and autoloop regulatory circuit. The Journal of biological chemistry 285, 11681\u201311691, https:\/\/doi.org\/10.1074\/jbc.M109.096107 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR16","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","volume":"161","author":"JL Goldstein","year":"2015","unstructured":"Goldstein, J. L. & Brown, M. S. A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161, 161\u2013172, https:\/\/doi.org\/10.1016\/j.cell.2015.01.036 (2015).","journal-title":"Cell"},{"key":"46594_CR17","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/0092-8674(94)90234-8","volume":"77","author":"X Wang","year":"1994","unstructured":"Wang, X., Sato, R., Brown, M. S., Hua, X. & Goldstein, J. L. SREBP-1, a membrane-bound transcription factor released by sterol-regulated proteolysis. Cell 77, 53\u201362 (1994).","journal-title":"Cell"},{"key":"46594_CR18","doi-asserted-by":"crossref","first-page":"17267","DOI":"10.1016\/S0021-9258(17)32550-4","volume":"269","author":"R Sato","year":"1994","unstructured":"Sato, R. et al. Assignment of the membrane attachment, DNA binding, and transcriptional activation domains of sterol regulatory element-binding protein-1 (SREBP-1). The Journal of biological chemistry 269, 17267\u201317273 (1994).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.cell.2005.12.022","volume":"124","author":"JL Goldstein","year":"2006","unstructured":"Goldstein, J. L., DeBose-Boyd, R. A. & Brown, M. S. Protein sensors for membrane sterols. Cell 124, 35\u201346, https:\/\/doi.org\/10.1016\/j.cell.2005.12.022 (2006).","journal-title":"Cell"},{"key":"46594_CR20","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0092-8674(00)81668-2","volume":"99","author":"RA DeBose-Boyd","year":"1999","unstructured":"DeBose-Boyd, R. A. et al. Transport-dependent proteolysis of SREBP: relocation of site-1 protease from Golgi to ER obviates the need for SREBP transport to Golgi. Cell 99, 703\u2013712 (1999).","journal-title":"Cell"},{"key":"46594_CR21","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S0092-8674(00)81304-5","volume":"85","author":"J Sakai","year":"1996","unstructured":"Sakai, J. et al. Sterol-regulated release of SREBP-2 from cell membranes requires two sequential cleavages, one within a transmembrane segment. Cell 85, 1037\u20131046 (1996).","journal-title":"Cell"},{"key":"46594_CR22","doi-asserted-by":"publisher","first-page":"11019","DOI":"10.1074\/jbc.M111041200","volume":"277","author":"SB Joseph","year":"2002","unstructured":"Joseph, S. B. et al. Direct and indirect mechanisms for regulation of fatty acid synthase gene expression by liver X receptors. The Journal of biological chemistry 277, 11019\u201311025, https:\/\/doi.org\/10.1074\/jbc.M111041200 (2002).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR23","doi-asserted-by":"publisher","first-page":"5453","DOI":"10.1074\/jbc.M610566200","volume":"282","author":"MJ Griffin","year":"2007","unstructured":"Griffin, M. J., Wong, R. H., Pandya, N. & Sul, H. S. Direct interaction between USF and SREBP-1c mediates synergistic activation of the fatty-acid synthase promoter. The Journal of biological chemistry 282, 5453\u20135467, https:\/\/doi.org\/10.1074\/jbc.M610566200 (2007).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR24","doi-asserted-by":"publisher","first-page":"e1000133","DOI":"10.1371\/journal.pgen.1000133","volume":"4","author":"BD Reed","year":"2008","unstructured":"Reed, B. D., Charos, A. E., Szekely, A. M., Weissman, S. M. & Snyder, M. Genome-wide occupancy of SREBP1 and its partners NFY and SP1 reveals novel functional roles and combinatorial regulation of distinct classes of genes. PLoS Genet 4, e1000133, https:\/\/doi.org\/10.1371\/journal.pgen.1000133 (2008).","journal-title":"PLoS Genet"},{"key":"46594_CR25","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1101\/gad.12.19.3020","volume":"12","author":"AM Naar","year":"1998","unstructured":"Naar, A. M. et al. Chromatin, TAFs, and a novel multiprotein coactivator are required for synergistic activation by Sp1 and SREBP-1a in vitro. Genes Dev 12, 3020\u20133031 (1998).","journal-title":"Genes Dev"},{"key":"46594_CR26","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/19789","volume":"398","author":"AM Naar","year":"1999","unstructured":"Naar, A. M. et al. Composite co-activator ARC mediates chromatin-directed transcriptional activation. Nature 398, 828\u2013832, https:\/\/doi.org\/10.1038\/19789 (1999).","journal-title":"Nature"},{"key":"46594_CR27","doi-asserted-by":"publisher","first-page":"2903","DOI":"10.1101\/gad.10.22.2903","volume":"10","author":"JD Oliner","year":"1996","unstructured":"Oliner, J. D., Andresen, J. M., Hansen, S. K., Zhou, S. & Tjian, R. SREBP transcriptional activity is mediated through an interaction with the CREB-binding protein. Genes Dev 10, 2903\u20132911 (1996).","journal-title":"Genes Dev"},{"key":"46594_CR28","doi-asserted-by":"publisher","first-page":"31078","DOI":"10.1074\/jbc.M005353200","volume":"275","author":"M Amemiya-Kudo","year":"2000","unstructured":"Amemiya-Kudo, M. et al. Promoter analysis of the mouse sterol regulatory element-binding protein-1c gene. The Journal of biological chemistry 275, 31078\u201331085, https:\/\/doi.org\/10.1074\/jbc.M005353200 (2000).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR29","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.bjc.6605007","volume":"100","author":"T Mashima","year":"2009","unstructured":"Mashima, T., Seimiya, H. & Tsuruo, T. De novo fatty-acid synthesis and related pathways as molecular targets for cancer therapy. British journal of cancer 100, 1369\u20131372, https:\/\/doi.org\/10.1038\/sj.bjc.6605007 (2009).","journal-title":"British journal of cancer"},{"key":"46594_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.cell.2012.01.014","volume":"148","author":"JE Dancey","year":"2012","unstructured":"Dancey, J. E., Bedard, P. L., Onetto, N. & Hudson, T. J. The genetic basis for cancer treatment decisions. Cell 148, 409\u2013420, https:\/\/doi.org\/10.1016\/j.cell.2012.01.014 (2012).","journal-title":"Cell"},{"key":"46594_CR31","doi-asserted-by":"publisher","first-page":"5219","DOI":"10.1200\/JCO.2009.27.4944","volume":"28","author":"LE Macconaill","year":"2010","unstructured":"Macconaill, L. E. & Garraway, L. A. Clinical implications of the cancer genome. J Clin Oncol 28, 5219\u20135228, https:\/\/doi.org\/10.1200\/JCO.2009.27.4944 (2010).","journal-title":"J Clin Oncol"},{"key":"46594_CR32","doi-asserted-by":"publisher","first-page":"2012","DOI":"10.1002\/ijc.29031","volume":"136","author":"SD Horne","year":"2015","unstructured":"Horne, S. D., Pollick, S. A. & Heng, H. H. Evolutionary mechanism unifies the hallmarks of cancer. Int J Cancer 136, 2012\u20132021, https:\/\/doi.org\/10.1002\/ijc.29031 (2015).","journal-title":"Int J Cancer"},{"key":"46594_CR33","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1200\/JCO.2012.45.2268","volume":"31","author":"R Dienstmann","year":"2013","unstructured":"Dienstmann, R., Rodon, J., Barretina, J. & Tabernero, J. Genomic medicine frontier in human solid tumors: prospects and challenges. J Clin Oncol 31, 1874\u20131884, https:\/\/doi.org\/10.1200\/JCO.2012.45.2268 (2013).","journal-title":"J Clin Oncol"},{"key":"46594_CR34","doi-asserted-by":"publisher","first-page":"3214","DOI":"10.1101\/gad.1609907","volume":"21","author":"SV Sharma","year":"2007","unstructured":"Sharma, S. V. & Settleman, J. Oncogene addiction: setting the stage for molecularly targeted cancer therapy. Genes Dev 21, 3214\u20133231, https:\/\/doi.org\/10.1101\/gad.1609907 (2007).","journal-title":"Genes Dev"},{"key":"46594_CR35","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1056\/NEJMra0804588","volume":"361","author":"SD Markowitz","year":"2009","unstructured":"Markowitz, S. D. & Bertagnolli, M. M. Molecular origins of cancer: Molecular basis of colorectal cancer. The New England journal of medicine 361, 2449\u20132460, https:\/\/doi.org\/10.1056\/NEJMra0804588 (2009).","journal-title":"The New England journal of medicine"},{"issue":"8","key":"46594_CR36","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.tig.2018.05.007","volume":"34","author":"Katherine L. Pogrebniak","year":"2018","unstructured":"Pogrebniak, K. L. & Curtis, C. Harnessing Tumor Evolution to Circumvent Resistance. Trends Genet, https:\/\/doi.org\/10.1016\/j.tig.2018.05.007 (2018).","journal-title":"Trends in Genetics"},{"key":"46594_CR37","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1146\/annurev-pathol-121808-102113","volume":"5","author":"JJ Salk","year":"2010","unstructured":"Salk, J. J., Fox, E. J. & Loeb, L. A. Mutational heterogeneity in human cancers: origin and consequences. Annu Rev Pathol 5, 51\u201375, https:\/\/doi.org\/10.1146\/annurev-pathol-121808-102113 (2010).","journal-title":"Annu Rev Pathol"},{"key":"46594_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.trecan.2015.11.003","volume":"2","author":"KA Lipinski","year":"2016","unstructured":"Lipinski, K. A. et al. Cancer Evolution and the Limits of Predictability in Precision Cancer Medicine. Trends. Cancer 2, 49\u201363, https:\/\/doi.org\/10.1016\/j.trecan.2015.11.003 (2016).","journal-title":"Cancer"},{"key":"46594_CR39","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1038\/537S106a","volume":"537","author":"C Brown","year":"2016","unstructured":"Brown, C. Targeted therapy: An elusive cancer target. Nature 537, S106\u2013108, https:\/\/doi.org\/10.1038\/537S106a (2016).","journal-title":"Nature"},{"key":"46594_CR40","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/nrc2664","volume":"9","author":"JA Engelman","year":"2009","unstructured":"Engelman, J. A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nature reviews. Cancer 9, 550\u2013562, https:\/\/doi.org\/10.1038\/nrc2664 (2009).","journal-title":"Nature reviews. Cancer"},{"key":"46594_CR41","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.ccell.2018.03.025","volume":"33","author":"DJ Konieczkowski","year":"2018","unstructured":"Konieczkowski, D. J., Johannessen, C. M. & Garraway, L. A. A Convergence-Based Framework for Cancer Drug Resistance. Cancer Cell 33, 801\u2013815, https:\/\/doi.org\/10.1016\/j.ccell.2018.03.025 (2018).","journal-title":"Cancer Cell"},{"key":"46594_CR42","first-page":"201","volume":"150","author":"A Rashid","year":"1997","unstructured":"Rashid, A. et al. Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. The American journal of pathology 150, 201\u2013208 (1997).","journal-title":"The American journal of pathology"},{"key":"46594_CR43","doi-asserted-by":"publisher","first-page":"e61204","DOI":"10.1371\/journal.pone.0061204","volume":"8","author":"Y Ide","year":"2013","unstructured":"Ide, Y. et al. Human breast cancer tissues contain abundant phosphatidylcholine(36ratio1) with high stearoyl-CoA desaturase-1 expression. PloS one 8, e61204, https:\/\/doi.org\/10.1371\/journal.pone.0061204 (2013).","journal-title":"PloS one"},{"key":"46594_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/S0090-4295(95)96904-7","volume":"45","author":"JI Epstein","year":"1995","unstructured":"Epstein, J. I., Carmichael, M. & Partin, A. W. OA-519 (fatty acid synthase) as an independent predictor of pathologic state in adenocarcinoma of the prostate. Urology 45, 81\u201386 (1995).","journal-title":"Urology"},{"key":"46594_CR45","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nature18003","volume":"534","author":"P Mertins","year":"2016","unstructured":"Mertins, P. et al. Proteogenomics connects somatic mutations to signalling in breast cancer. Nature 534, 55\u201362, https:\/\/doi.org\/10.1038\/nature18003 (2016).","journal-title":"Nature"},{"key":"46594_CR46","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/0006-3002(60)91390-1","volume":"40","author":"NL Bucher","year":"1960","unstructured":"Bucher, N. L., Overath, P. & Lynen, F. beta-Hydroxy-beta-methyl-glutaryl coenzyme A reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liver. Biochimica et biophysica acta 40, 491\u2013501 (1960).","journal-title":"Biochimica et biophysica acta"},{"key":"46594_CR47","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1038\/ng.2653","volume":"45","author":"GT Consortium","year":"2013","unstructured":"Consortium, G. T. The Genotype-Tissue Expression (GTEx) project. Nat Genet 45, 580\u2013585, https:\/\/doi.org\/10.1038\/ng.2653 (2013).","journal-title":"Nat Genet"},{"key":"46594_CR48","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller, A. J. & Mihm, M. C. Jr. Melanoma. The New England journal of medicine 355, 51\u201365, https:\/\/doi.org\/10.1056\/NEJMra052166 (2006).","journal-title":"The New England journal of medicine"},{"key":"46594_CR49","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1126\/science.aad0501","volume":"352","author":"I Tirosh","year":"2016","unstructured":"Tirosh, I. et al. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352, 189\u2013196, https:\/\/doi.org\/10.1126\/science.aad0501 (2016).","journal-title":"Science"},{"key":"46594_CR50","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-017-3529-5","volume":"17","author":"MV Heppt","year":"2017","unstructured":"Heppt, M. V. et al. Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care. BMC Cancer 17, 536, https:\/\/doi.org\/10.1186\/s12885-017-3529-5 (2017).","journal-title":"BMC Cancer"},{"key":"46594_CR51","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1146\/annurev.pharmtox.010909.105654","volume":"50","author":"CF Bennett","year":"2010","unstructured":"Bennett, C. F. & Swayze, E. E. RNA targeting therapeutics: molecular mechanisms of antisense oligonucleotides as a therapeutic platform. Annual review of pharmacology and toxicology 50, 259\u2013293, https:\/\/doi.org\/10.1146\/annurev.pharmtox.010909.105654 (2010).","journal-title":"Annual review of pharmacology and toxicology"},{"key":"46594_CR52","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1194\/jlr.M100417-JLR200","volume":"43","author":"M Amemiya-Kudo","year":"2002","unstructured":"Amemiya-Kudo, M. et al. Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. Journal of lipid research 43, 1220\u20131235 (2002).","journal-title":"Journal of lipid research"},{"key":"46594_CR53","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1194\/jlr.M064022","volume":"57","author":"L Vergnes","year":"2016","unstructured":"Vergnes, L. et al. SREBP-2-deficient and hypomorphic mice reveal roles for SREBP-2 in embryonic development and SREBP-1c expression. Journal of lipid research 57, 410\u2013421, https:\/\/doi.org\/10.1194\/jlr.M064022 (2016).","journal-title":"Journal of lipid research"},{"key":"46594_CR54","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.tem.2011.10.004","volume":"23","author":"TI Jeon","year":"2012","unstructured":"Jeon, T. I. & Osborne, T. F. SREBPs: metabolic integrators in physiology and metabolism. Trends Endocrinol Metab 23, 65\u201372, https:\/\/doi.org\/10.1016\/j.tem.2011.10.004 (2012).","journal-title":"Trends Endocrinol Metab"},{"key":"46594_CR55","doi-asserted-by":"publisher","first-page":"e0215022","DOI":"10.1371\/journal.pone.0215022","volume":"14","author":"S Wu","year":"2019","unstructured":"Wu, S. & Naar, A. M. A lipid-free and insulin-supplemented medium supports De Novo fatty acid synthesis gene activation in melanoma cells. PloS one 14, e0215022, https:\/\/doi.org\/10.1371\/journal.pone.0215022 (2019).","journal-title":"PloS one"},{"key":"46594_CR56","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1172\/JCI119247","volume":"99","author":"I Shimomura","year":"1997","unstructured":"Shimomura, I., Shimano, H., Horton, J. D., Goldstein, J. L. & Brown, M. S. Differential expression of exons 1a and 1c in mRNAs for sterol regulatory element binding protein-1 in human and mouse organs and cultured cells. The Journal of clinical investigation 99, 838\u2013845, https:\/\/doi.org\/10.1172\/JCI119247 (1997).","journal-title":"The Journal of clinical investigation"},{"key":"46594_CR57","doi-asserted-by":"publisher","first-page":"8288","DOI":"10.1128\/MCB.24.18.8288-8300.2004","volume":"24","author":"JI Toth","year":"2004","unstructured":"Toth, J. I., Datta, S., Athanikar, J. N., Freedman, L. P. & Osborne, T. F. Selective coactivator interactions in gene activation by SREBP-1a and -1c. Molecular and cellular biology 24, 8288\u20138300, https:\/\/doi.org\/10.1128\/MCB.24.18.8288-8300.2004 (2004).","journal-title":"Molecular and cellular biology"},{"key":"46594_CR58","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/j.cytogfr.2014.07.016","volume":"25","author":"LM Sedger","year":"2014","unstructured":"Sedger, L. M. & McDermott, M. F. TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future. Cytokine Growth Factor Rev 25, 453\u2013472, https:\/\/doi.org\/10.1016\/j.cytogfr.2014.07.016 (2014).","journal-title":"Cytokine Growth Factor Rev"},{"key":"46594_CR59","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3945\/an.110.000125","volume":"2","author":"X Liu","year":"2011","unstructured":"Liu, X., Strable, M. S. & Ntambi, J. M. Stearoyl CoA desaturase 1: role in cellular inflammation and stress. Adv Nutr 2, 15\u201322, https:\/\/doi.org\/10.3945\/an.110.000125 (2011).","journal-title":"Adv Nutr"},{"key":"46594_CR60","doi-asserted-by":"publisher","first-page":"17732","DOI":"10.1074\/jbc.M500796200","volume":"280","author":"AJ Bannister","year":"2005","unstructured":"Bannister, A. J. et al. Spatial distribution of di- and tri-methyl lysine 36 of histone H3 at active genes. The Journal of biological chemistry 280, 17732\u201317736, https:\/\/doi.org\/10.1074\/jbc.M500796200 (2005).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR61","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1038\/nrg3293","volume":"13","author":"K Adelman","year":"2012","unstructured":"Adelman, K. & Lis, J. T. Promoter-proximal pausing of RNA polymerase II: emerging roles in metazoans. Nat Rev Genet 13, 720\u2013731, https:\/\/doi.org\/10.1038\/nrg3293 (2012).","journal-title":"Nat Rev Genet"},{"key":"46594_CR62","doi-asserted-by":"publisher","first-page":"2452","DOI":"10.1101\/gad.824700","volume":"14","author":"P Komarnitsky","year":"2000","unstructured":"Komarnitsky, P., Cho, E. J. & Buratowski, S. Different phosphorylated forms of RNA polymerase II and associated mRNA processing factors during transcription. Genes Dev 14, 2452\u20132460 (2000).","journal-title":"Genes Dev"},{"key":"46594_CR63","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.bbalip.2013.07.008","volume":"1831","author":"SM Louie","year":"2013","unstructured":"Louie, S. M., Roberts, L. S., Mulvihill, M. M., Luo, K. & Nomura, D. K. Cancer cells incorporate and remodel exogenous palmitate into structural and oncogenic signaling lipids. Biochimica et biophysica acta 1831, 1566\u20131572, https:\/\/doi.org\/10.1016\/j.bbalip.2013.07.008 (2013).","journal-title":"Biochimica et biophysica acta"},{"key":"46594_CR64","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1056\/NEJMoa1103782","volume":"364","author":"PB Chapman","year":"2011","unstructured":"Chapman, P. B. et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. The New England journal of medicine 364, 2507\u20132516, https:\/\/doi.org\/10.1056\/NEJMoa1103782 (2011).","journal-title":"The New England journal of medicine"},{"key":"46594_CR65","doi-asserted-by":"publisher","first-page":"e371","DOI":"10.1016\/S1470-2045(14)70072-5","volume":"15","author":"AM Menzies","year":"2014","unstructured":"Menzies, A. M. & Long, G. V. Systemic treatment for BRAF-mutant melanoma: where do we go next? The Lancet. Oncology 15, e371\u2013381, https:\/\/doi.org\/10.1016\/S1470-2045(14)70072-5 (2014).","journal-title":"The Lancet. Oncology"},{"key":"46594_CR66","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S0140-6736(13)60802-8","volume":"383","author":"AM Eggermont","year":"2014","unstructured":"Eggermont, A. M., Spatz, A. & Robert, C. Cutaneous melanoma. Lancet 383, 816\u2013827, https:\/\/doi.org\/10.1016\/S0140-6736(13)60802-8 (2014).","journal-title":"Lancet"},{"key":"46594_CR67","doi-asserted-by":"publisher","first-page":"E697","DOI":"10.1210\/jc.2014-2764","volume":"100","author":"CA von Roemeling","year":"2015","unstructured":"von Roemeling, C. A. et al. Aberrant lipid metabolism in anaplastic thyroid carcinoma reveals stearoyl CoA desaturase 1 as a novel therapeutic target. J Clin Endocrinol Metab 100, E697\u2013709, https:\/\/doi.org\/10.1210\/jc.2014-2764 (2015).","journal-title":"J Clin Endocrinol Metab"},{"key":"46594_CR68","doi-asserted-by":"publisher","first-page":"5434","DOI":"10.1158\/1078-0432.CCR-15-0126","volume":"21","author":"SF Jones","year":"2015","unstructured":"Jones, S. F. & Infante, J. R. Molecular Pathways: Fatty Acid Synthase. Clinical cancer research: an official journal of the American Association for Cancer Research 21, 5434\u20135438, https:\/\/doi.org\/10.1158\/1078-0432.CCR-15-0126 (2015).","journal-title":"Clinical cancer research: an official journal of the American Association for Cancer Research"},{"key":"46594_CR69","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1038\/nchembio.1603","volume":"10","author":"MA Hardwicke","year":"2014","unstructured":"Hardwicke, M. A. et al. A human fatty acid synthase inhibitor binds beta-ketoacyl reductase in the keto-substrate site. Nat Chem Biol 10, 774\u2013779, https:\/\/doi.org\/10.1038\/nchembio.1603 (2014).","journal-title":"Nat Chem Biol"},{"issue":"15","key":"46594_CR70","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1093\/bioinformatics\/btx162","volume":"33","author":"Aleksandr Ianevski","year":"2017","unstructured":"Aleksandr, I., He, L., Aittokallio, T. & Tang, J. SynergyFinder: a web application for analyzing drug combination dose-response matrix data. Bioinformatics, https:\/\/doi.org\/10.1093\/bioinformatics\/btx162 (2017).","journal-title":"Bioinformatics"},{"key":"46594_CR71","doi-asserted-by":"publisher","first-page":"253","DOI":"10.2203\/dose-response.09-049.Reynolds","volume":"8","author":"AR Reynolds","year":"2010","unstructured":"Reynolds, A. R. Potential relevance of bell-shaped and u-shaped dose-responses for the therapeutic targeting of angiogenesis in cancer. Dose Response 8, 253\u2013284, https:\/\/doi.org\/10.2203\/dose-response.09-049.Reynolds (2010).","journal-title":"Dose Response"},{"key":"46594_CR72","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","volume":"23","author":"R Haq","year":"2013","unstructured":"Haq, R. et al. Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF. Cancer Cell 23, 302\u2013315, https:\/\/doi.org\/10.1016\/j.ccr.2013.02.003 (2013).","journal-title":"Cancer Cell"},{"key":"46594_CR73","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","volume":"23","author":"F Vazquez","year":"2013","unstructured":"Vazquez, F. et al. PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell 23, 287\u2013301, https:\/\/doi.org\/10.1016\/j.ccr.2012.11.020 (2013).","journal-title":"Cancer Cell"},{"key":"46594_CR74","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1016\/S0140-6736(12)60398-5","volume":"379","author":"GS Falchook","year":"2012","unstructured":"Falchook, G. S. et al. Dabrafenib in patients with melanoma, untreated brain metastases, and other solid tumours: a phase 1 dose-escalation trial. Lancet 379, 1893\u20131901, https:\/\/doi.org\/10.1016\/S0140-6736(12)60398-5 (2012).","journal-title":"Lancet"},{"key":"46594_CR75","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1177\/1758834014566428","volume":"7","author":"SJ Welsh","year":"2015","unstructured":"Welsh, S. J. & Corrie, P. G. Management of BRAF and MEK inhibitor toxicities in patients with metastatic melanoma. Ther Adv Med Oncol 7, 122\u2013136, https:\/\/doi.org\/10.1177\/1758834014566428 (2015).","journal-title":"Ther Adv Med Oncol"},{"key":"46594_CR76","doi-asserted-by":"publisher","first-page":"28087","DOI":"10.1074\/jbc.M112.377218","volume":"287","author":"V Yadav","year":"2012","unstructured":"Yadav, V. et al. Reactivation of mitogen-activated protein kinase (MAPK) pathway by FGF receptor 3 (FGFR3)\/Ras mediates resistance to vemurafenib in human B-RAF V600E mutant melanoma. The Journal of biological chemistry 287, 28087\u201328098, https:\/\/doi.org\/10.1074\/jbc.M112.377218 (2012).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR77","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1158\/2159-8290.CD-13-0070","volume":"3","author":"EJ Morris","year":"2013","unstructured":"Morris, E. J. et al. Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors. Cancer Discov 3, 742\u2013750, https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0070 (2013).","journal-title":"Cancer Discov"},{"key":"46594_CR78","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nature24037","volume":"550","author":"X Kong","year":"2017","unstructured":"Kong, X. et al. Cancer drug addiction is relayed by an ERK2-dependent phenotype switch. Nature 550, 270\u2013274, https:\/\/doi.org\/10.1038\/nature24037 (2017).","journal-title":"Nature"},{"key":"46594_CR79","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.tem.2010.01.001","volume":"21","author":"JR Krycer","year":"2010","unstructured":"Krycer, J. R., Sharpe, L. J., Luu, W. & Brown, A. J. The Akt-SREBP nexus: cell signaling meets lipid metabolism. Trends Endocrinol Metab 21, 268\u2013276, https:\/\/doi.org\/10.1016\/j.tem.2010.01.001 (2010).","journal-title":"Trends Endocrinol Metab"},{"issue":"2","key":"46594_CR80","doi-asserted-by":"publisher","first-page":"a029652","DOI":"10.1101\/cshperspect.a029652","volume":"7","author":"Angelo Fortunato","year":"2016","unstructured":"Fortunato, A. et al. Natural Selection in Cancer Biology: From Molecular Snowflakes to Trait Hallmarks. Cold Spring Harb Perspect Med 7, https:\/\/doi.org\/10.1101\/cshperspect.a029652 (2017).","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"46594_CR81","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan, D. & Weinberg, R. A. The hallmarks of cancer. Cell 100, 57\u201370 (2000).","journal-title":"Cell"},{"key":"46594_CR82","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646\u2013674, https:\/\/doi.org\/10.1016\/j.cell.2011.02.013 (2011).","journal-title":"Cell"},{"key":"46594_CR83","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1002\/emmm.201100176","volume":"3","author":"D Torti","year":"2011","unstructured":"Torti, D. & Trusolino, L. Oncogene addiction as a foundational rationale for targeted anti-cancer therapy: promises and perils. EMBO Mol Med 3, 623\u2013636, https:\/\/doi.org\/10.1002\/emmm.201100176 (2011).","journal-title":"EMBO Mol Med"},{"key":"46594_CR84","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.cmet.2017.08.011","volume":"26","author":"CW Kim","year":"2017","unstructured":"Kim, C. W. et al. Acetyl CoA Carboxylase Inhibition Reduces Hepatic Steatosis but Elevates Plasma Triglycerides in Mice and Humans: A Bedside to Bench Investigation. Cell Metab 26, 576, https:\/\/doi.org\/10.1016\/j.cmet.2017.08.011 (2017).","journal-title":"Cell Metab"},{"key":"46594_CR85","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.molcel.2017.09.020","volume":"68","author":"W Wan","year":"2017","unstructured":"Wan, W. et al. mTORC1 Phosphorylates Acetyltransferase p300 to Regulate Autophagy and Lipogenesis. Molecular cell 68, 323\u2013335 e326, https:\/\/doi.org\/10.1016\/j.molcel.2017.09.020 (2017).","journal-title":"Molecular cell"},{"key":"46594_CR86","doi-asserted-by":"publisher","first-page":"33959","DOI":"10.1074\/jbc.M110.122978","volume":"285","author":"B Ponugoti","year":"2010","unstructured":"Ponugoti, B. et al. SIRT1 deacetylates and inhibits SREBP-1C activity in regulation of hepatic lipid metabolism. The Journal of biological chemistry 285, 33959\u201333970, https:\/\/doi.org\/10.1074\/jbc.M110.122978 (2010).","journal-title":"The Journal of biological chemistry"},{"key":"46594_CR87","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/ng.322","volume":"41","author":"P Kolasinska-Zwierz","year":"2009","unstructured":"Kolasinska-Zwierz, P. et al. Differential chromatin marking of introns and expressed exons by H3K36me3. Nat Genet 41, 376\u2013381, https:\/\/doi.org\/10.1038\/ng.322 (2009).","journal-title":"Nat Genet"},{"key":"46594_CR88","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nrc3760","volume":"14","author":"M Holderfield","year":"2014","unstructured":"Holderfield, M., Deuker, M. M., McCormick, F. & McMahon, M. Targeting RAF kinases for cancer therapy: BRAF-mutated melanoma and beyond. Nature reviews. Cancer 14, 455\u2013467, https:\/\/doi.org\/10.1038\/nrc3760 (2014).","journal-title":"Nature reviews. Cancer"},{"key":"46594_CR89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1056\/NEJMoa1412690","volume":"372","author":"C Robert","year":"2015","unstructured":"Robert, C. et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. The New England journal of medicine 372, 30\u201339, https:\/\/doi.org\/10.1056\/NEJMoa1412690 (2015).","journal-title":"The New England journal of medicine"},{"key":"46594_CR90","doi-asserted-by":"publisher","first-page":"1867","DOI":"10.1056\/NEJMoa1408868","volume":"371","author":"J Larkin","year":"2014","unstructured":"Larkin, J. et al. Combined vemurafenib and cobimetinib in BRAF-mutated melanoma. The New England journal of medicine 371, 1867\u20131876, https:\/\/doi.org\/10.1056\/NEJMoa1408868 (2014).","journal-title":"The New England journal of medicine"},{"key":"46594_CR91","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1158\/2159-8290.CD-13-0642","volume":"4","author":"H Shi","year":"2014","unstructured":"Shi, H. et al. Acquired resistance and clonal evolution in melanoma during BRAF inhibitor therapy. Cancer Discov 4, 80\u201393, https:\/\/doi.org\/10.1158\/2159-8290.CD-13-0642 (2014).","journal-title":"Cancer Discov"},{"key":"46594_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04664-0","volume":"9","author":"A Talebi","year":"2018","unstructured":"Talebi, A. et al. Sustained SREBP-1-dependent lipogenesis as a key mediator of resistance to BRAF-targeted therapy. Nat Commun 9, 2500, https:\/\/doi.org\/10.1038\/s41467-018-04664-0 (2018).","journal-title":"Nat Commun"},{"key":"46594_CR93","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1056\/NEJMoa1305133","volume":"369","author":"O Hamid","year":"2013","unstructured":"Hamid, O. et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. The New England journal of medicine 369, 134\u2013144, https:\/\/doi.org\/10.1056\/NEJMoa1305133 (2013).","journal-title":"The New England journal of medicine"},{"key":"46594_CR94","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/S0140-6736(18)30533-6","volume":"391","author":"JJ Moslehi","year":"2018","unstructured":"Moslehi, J. J., Salem, J. E., Sosman, J. A., Lebrun-Vignes, B. & Johnson, D. B. Increased reporting of fatal immune checkpoint inhibitor-associated myocarditis. Lancet 391, 933, https:\/\/doi.org\/10.1016\/S0140-6736(18)30533-6 (2018).","journal-title":"Lancet"},{"key":"46594_CR95","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/nprot.2007.319","volume":"2","author":"JR Masters","year":"2007","unstructured":"Masters, J. R. & Stacey, G. N. Changing medium and passaging cell lines. Nat Protoc 2, 2276\u20132284, https:\/\/doi.org\/10.1038\/nprot.2007.319 (2007).","journal-title":"Nat Protoc"},{"key":"46594_CR96","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/nbt.3772","volume":"35","author":"J Vivian","year":"2017","unstructured":"Vivian, J. et al. Toil enables reproducible, open source, big biomedical data analyses. Nat Biotechnol 35, 314\u2013316, https:\/\/doi.org\/10.1038\/nbt.3772 (2017).","journal-title":"Nat Biotechnol"},{"key":"46594_CR97","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao, J. et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6, pl1, https:\/\/doi.org\/10.1126\/scisignal.2004088 (2013).","journal-title":"Sci Signal"},{"key":"46594_CR98","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1038\/nprot.2008.73","volume":"3","author":"TD Schmittgen","year":"2008","unstructured":"Schmittgen, T. D. & Livak, K. J. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3, 1101\u20131108 (2008).","journal-title":"Nat Protoc"},{"key":"46594_CR99","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321, https:\/\/doi.org\/10.1093\/bioinformatics\/bts635 (2013).","journal-title":"Bioinformatics"},{"key":"46594_CR100","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1093\/bioinformatics\/btu638","volume":"31","author":"S Anders","year":"2015","unstructured":"Anders, S., Pyl, P. T. & Huber, W. HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31, 166\u2013169, https:\/\/doi.org\/10.1093\/bioinformatics\/btu638 (2015).","journal-title":"Bioinformatics"},{"key":"46594_CR101","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15, 550, https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol"},{"key":"46594_CR102","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature11247","volume":"489","author":"EP Consortium","year":"2012","unstructured":"Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57\u201374, https:\/\/doi.org\/10.1038\/nature11247 (2012).","journal-title":"Nature"},{"key":"46594_CR103","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/bioinformatics\/btv145","volume":"31","author":"G Yu","year":"2015","unstructured":"Yu, G., Wang, L. G. & He, Q. Y. ChIPseeker: an R\/Bioconductor package for ChIP peak annotation, comparison and visualization. Bioinformatics 31, 2382\u20132383, https:\/\/doi.org\/10.1093\/bioinformatics\/btv145 (2015).","journal-title":"Bioinformatics"},{"key":"46594_CR104","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-9-488","volume":"9","author":"T Hulsen","year":"2008","unstructured":"Hulsen, T., de Vlieg, J. & Alkema, W. BioVenn - a web application for the comparison and visualization of biological lists using area-proportional Venn diagrams. BMC Genomics 9, 488, https:\/\/doi.org\/10.1186\/1471-2164-9-488 (2008).","journal-title":"BMC Genomics"},{"key":"46594_CR105","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1093\/bioinformatics\/btp101","volume":"25","author":"G Bindea","year":"2009","unstructured":"Bindea, G. et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25, 1091\u20131093, https:\/\/doi.org\/10.1093\/bioinformatics\/btp101 (2009).","journal-title":"Bioinformatics"},{"key":"46594_CR106","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-10-161","volume":"10","author":"W Luo","year":"2009","unstructured":"Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161, https:\/\/doi.org\/10.1186\/1471-2105-10-161 (2009).","journal-title":"BMC Bioinformatics"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46594-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46594-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T11:35:25Z","timestamp":1671276925000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-46594-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,17]]},"references-count":106,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["46594"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-46594-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,17]]},"assertion":[{"value":"30 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"10369"}}